INSIGHTS ON DRUG DEVELOPMENT

• Immuno-Oncology Biomarker Measurement With High Sensitivity And Speed

  Explore results demonstrating the successful use of innovative ELISA assays to detect three key biomarkers: Programmed Death Ligand 1 (PD-L1), Interleukin-8 (IL-8), and Interferon Gamma (IFN-γ).

• Doubling Up For Speed In Biomanufacturing

  Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.

• Formulation Development Of Enterically Protected Spray Dried Dispersions

  Adrulipase spray-dried dispersions were evaluated to create an orally delivered, enteric-protected enzyme. The lead formulation provided the best acid protection, rapid release, and stability.

• A CDMO Is The Nexus Between Green Chemistry And Commercialization

  Modern R&D transforms sustainability from an optional add-on into a strategic optimization tool, enhancing cost-efficiency, speed to market, and process intensification for drug developers.

• R&D Excellence at Asymchem's UK Facility

  3/12/2026

  Dave Henderson, Head of R&D Labs, at Asymchem Sandwich Site, UK, leads state-of-the-art R&D laboratories dedicated to small molecule process development and cGMP manufacturing.

   

• A New Framework For Identifying Nitrosamine Risks And Derisking Products

  6/18/2024

  Examine a new methodology that holds significant promise for identifying APIs at risk for NDSRI formation, enabling manufacturers to prioritize risk mitigation strategies and ensure compliance.

• A Study To Assess Organoid Size And Cell Count From 3D Image Analysis

  4/4/2025

  Recent advancements in 3D patient-derived organoids (PDOs) offer improved predictive power over traditional 2D assays. Explore a patented bioprocess for PDO expansion that could revolutionize drug discovery, especially in oncology.

• Overcoming Excipient Risks And Challenges For Parenteral Formulations

  8/27/2025

  Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.

• Highly Sensitive ELISAs In 90 Minutes

  9/11/2024

  Traditional ELISA methods are often limited by their relatively low throughput and need for multiple wash steps. Learn about a solution that overcomes these challenges and provides rapid results.